Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Ethamcip 500mg

Generic: Ethamsylateby Cipla Limited

Buy Ethamcip 500mg (Ethamsylate) online | SafeRxPills

Strength

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Cabanex 0.5mg (Cabergoline) online | SafeRxPills

Cabanex 0.5mg

$81.60View
Buy Caberlin 0.25mg (Cabergoline) online | SafeRxPills

Caberlin 0.25mg

$21.00View
Caberlin 0.5mg tablet pack

Caberlin 0.5mg

$42.00View
Buy Cabgolin 0.25mg (Cabergoline) online | SafeRxPills

Cabgolin 0.25mg

$21.00View

About Ethamcip 500mg

Ethamcip 500mg is Cipla's etamsylate (also spelled ethamsylate) 500 mg tablet, sold in India for bleeding from small blood vessels, mainly heavy menstrual bleeding. Etamsylate is not a hormone and not a clotting factor: the labels say it acts on platelet adhesion and the resistance of small blood vessel walls. We sell it in packs of 30 and 60 tablets, from $0.75 a tablet in the 60 pack.

We have to be plain about this medicine. The evidence that etamsylate reduces heavy periods is weak. In a randomised trial that measured blood loss against tranexamic acid and mefenamic acid, etamsylate did not reduce mean menstrual blood loss, while tranexamic acid cut it by 54% (Bonnar 1996). NICE's 2007 heavy menstrual bleeding guideline (CG44, replaced by NG88 in 2018) said "Etamsylate should not be used for the treatment of HMB", and the current guideline, NG88, does not list etamsylate among the treatments it recommends. France's health technology body rated the medical benefit of Dicynone, the etamsylate brand licensed there, as insufficient in all its indications. Etamsylate is not approved in the US or Canada, and the UK Dicynene 500 tablet is listed as discontinued. So we would not recommend Ethamcip as a treatment for heavy periods when better tested options exist, and heavy bleeding needs a doctor's assessment first. This page sets out what the labels say, what the evidence shows and what to ask your doctor about instead.

Ethamcip 500mg at a glance

Active ingredientEtamsylate (ethamsylate) 500 mg per tablet, a non-hormonal haemostatic
Brand and makerEthamcip, Cipla Ltd (Apollo Pharmacy, Truemeds). PharmEasy lists it as "Made by CIPLA GX" and gives the manufacturer address as Pure & Cure Healthcare Pvt. Ltd., an Akums subsidiary in Haridwar
Regulatory statusNot approved by the FDA or Health Canada (no etamsylate product in either database). In the UK, Dicynene 500 tablets are listed as discontinued and not available. Australian status not confirmed. Licensed in France as Dicynone 500 mg, without prescription and not reimbursed. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada
Usual dose from the labelsThree 500 mg tablets a day (French Dicynone tablet label); one 500 mg tablet three times a day for 10 days, starting 5 days before the expected period (OM Pharma capsule and Indian Torrent labels). NICE's 2007 guideline described 500 mg four times a day from, but not before, the start of bleeding
Half-lifeAbout 8 hours (French label 5.2) or about 3.7 hours (OM Pharma and Indian Torrent labels); peak blood levels about 4 hours after a 500 mg dose
Packs30 and 60 tablets (Indian strips hold 10)
Price per tablet$0.83 (30 pack) or $0.75 (60 pack), before shipping
Delivery7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149

Price per tablet

Prices below are as of October 2026; the pack selector shows the current price.

PackPricePer tabletShippingPer tablet with shipping
30 tablets$25$0.83$25$1.67
60 tablets$45$0.75$25$1.17

Both packs are under the $149 free shipping line, so a single pack carries $25 shipping, which doubles the cost of the 30 pack. The 60 pack is cheaper per tablet before shipping too.

How long a pack lasts. On the 10 day schedule in the OM Pharma and Indian Torrent labels (one 500 mg tablet three times a day), one cycle uses 30 tablets, so the 30 pack covers one cycle and the 60 pack two. On the four times a day schedule NICE described in 2007, taken for 5 days of bleeding as in the Bonnar trial, a cycle uses 20 tablets. These are our arithmetic, not label figures. Do not buy several cycles' worth before a doctor has looked for the cause of the bleeding; the labels say that if bleeding does not improve, possible causes must be looked for and excluded.

Compared with US treatments

There is no etamsylate in the US to compare with: openFDA lists no approved etamsylate product and NADAC has no etamsylate rows. The closest US prescription option for heavy periods is generic tranexamic acid 650 mg tablets.

Ethamcip 500mg (ours)US generic tranexamic acid 650 mg
MakerCipla (India)Several US generic makers
FDA approvedNo (etamsylate is not approved in the US)Yes, for cyclic heavy menstrual bleeding
Label dose per cycle30 tablets (10 day schedule)Two tablets three times a day for up to 5 days, so up to 30 tablets
Cost per tablet$0.75 to $0.83 before shippingAbout $0.83 (NADAC $0.82949)
Cost of one cycleAbout $22.50 to $25 before shippingAbout $24.88 at NADAC for the full 5 day course

NADAC is the average price US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price at the counter. The NADAC rate for generic tranexamic acid 650 mg was $0.82949 a tablet in the file effective 21 October 2026. The cycle costs are our arithmetic. The cost is about the same, but tranexamic acid has far better evidence for heavy periods, so US readers with a prescription should ask about it before considering etamsylate. Tranexamic acid has its own risks: for example, the US label contraindicates it with combined hormonal contraception because of blood clot reports, so it is a decision for your doctor.

What the evidence says

  • Bonnar and Sheppard 1996 (BMJ, PMID 8806245). 76 women with heavy periods and no other cause found were randomised to etamsylate 500 mg six hourly, mefenamic acid 500 mg eight hourly or tranexamic acid 1 g six hourly, for 5 days from the first day of bleeding, over three cycles. Blood loss was measured in the laboratory. "Ethamsylate did not reduce mean menstrual blood loss"; mefenamic acid reduced it by 20% (186 ml to 148 ml) and tranexamic acid by 54% (164 ml to 75 ml).
  • Cochrane review of antifibrinolytics, 2018 (Bryant-Smith, PMID 29656433). Against etamsylate, tranexamic acid reduced mean blood loss by 100 mL per cycle (one trial, 53 women, low quality evidence). The authors concluded that tranexamic acid "appears effective" compared with placebo, NSAIDs, oral luteal progestogens, ethamsylate or herbal remedies.
  • Cochrane review of NSAIDs, 2019 (Bofill Rodriguez, PMID 31535715). There was no clear evidence of a difference between NSAIDs and etamsylate, but most studies were underpowered.
  • NICE 2007 (CG44 full guideline, section 8.12; CG44 was replaced by NG88 in 2018). One review that pooled four studies found etamsylate reduced blood loss by 13.1% (95% CI 10.9% to 15.3%), "less than most other interventions". NICE called the evidence insufficient and recommended in 2007: "Etamsylate should not be used for the treatment of HMB."
  • NICE NG88 (2018, last updated July 2026). The recommendations of the current guideline, which replaced CG44, do not mention etamsylate. It recommends considering a levonorgestrel intrauterine system as the first treatment for women with no identified pathology, fibroids under 3 cm that do not distort the womb cavity, or suspected or diagnosed adenomyosis, and, if that is declined or not suitable, tranexamic acid, NSAIDs, combined hormonal contraception or cyclical oral progestogens (1.5.2, 1.5.3).
  • France. The French public medicines database records the Haute Autorité de Santé opinion of 8 June 2005: the medical benefit of these products is "insuffisant" (insufficient) in all their indications. Dicynone 500 mg is still licensed there, without prescription, and is not reimbursed.

These trials are small and old, and none tested Cipla's Ethamcip itself. But no evidence we found shows etamsylate working as well as tranexamic acid, NSAIDs or hormonal options.

Heavy periods need a diagnosis first

Heavy menstrual bleeding is a symptom, not a diagnosis. The French label licenses etamsylate for heavy or irregular uterine bleeding only as an add-on treatment after the cause has been investigated, and the OM Pharma label only when no organic cause is present. NICE NG88 says doctors should:

  • do a full blood count for every woman with heavy menstrual bleeding, alongside any treatment (1.2.6). In July 2026 NICE removed its old advice against routine ferritin testing "because of the risk of iron deficiency in this population"
  • consider testing for a clotting disorder such as von Willebrand disease if heavy bleeding started with the first periods and there is a personal or family history that suggests one (1.2.7)
  • offer outpatient hysteroscopy when the history suggests fibroids inside the womb, polyps or a problem with the womb lining (1.3.4)
  • consider an endometrial biopsy for women at high risk of womb lining disease: persistent bleeding between periods or persistent irregular bleeding, infrequent heavy bleeding with obesity or polycystic ovary syndrome, tamoxifen use, or treatment that has not worked (1.3.10)

See a doctor before you take any medicine for heavy periods, and go back if bleeding does not improve: the French, OM Pharma and Indian Torrent labels all say that if heavy or prolonged bleeding does not improve, possible causes must be looked for and excluded.

Which strength to choose

DoseProductHow it fits the labels
250 mgEthamcip 250mgTwo tablets make one 500 mg dose
500 mg per doseEthamcip 500mgThe single dose in every label we checked
1,500 mg a dayThree Ethamcip 500mg tabletsFrench tablet label; OM Pharma and Indian Torrent labels for menstrual bleeding
2,000 mg a dayFour Ethamcip 500mg tabletsThe schedule NICE described in 2007 and the dose used in the Bonnar trial

None of the labels we read sets a higher dose for heavy periods, and none suggests that more tablets work better. The Torrent label says the 500 mg tablet "is not appropriate for children".

How to take Ethamcip 500mg

  1. Only after a doctor has assessed the bleeding, and as they prescribe.
  2. The OM Pharma and Indian Torrent labels say one 500 mg tablet three times a day with meals and a little water, for 10 days, starting 5 days before the expected period. The French label gives three tablets a day by mouth without a schedule.
  3. Do not combine it with tranexamic acid or another bleeding medicine unless your doctor tells you to.
  4. If you need a blood test, the French label says to give the sample before your first dose of the day, because etamsylate can make an enzymatic creatinine test read falsely low (4.5).
  5. If you develop a fever, stop: the French label says that if fever appears, treatment must be stopped and must not be restarted (4.4).
  6. If bleeding does not improve, go back to your doctor rather than taking more tablets.

Ethamcip is not a contraceptive. No etamsylate label lists contraception, and it will not prevent pregnancy.

Side effects

EffectFrequency in the labelSource
Nausea, diarrhoea, abdominal discomfortCommonIrish Dicynene SmPC 4.8 (adults)
Headache, rash, weakness (asthenia)CommonIrish Dicynene SmPC 4.8 (adults)
Joint painRareIrish Dicynene SmPC 4.8
Fever, blood clots (thromboembolism), low blood pressureVery rareIrish Dicynene SmPC 4.8
Agranulocytosis, neutropenia (very low white cells), thrombocytopenia (low platelets)Very rareIrish Dicynene SmPC 4.8; French label lists agranulocytosis and neutropenia as frequency not known
Allergic reactions, mainly hives, which mean treatment must stopFrequency not knownFrench Dicynone 500 mg tablet label 4.8
Nausea, diarrhoea, vomiting, rash, fever, headacheFrequency not knownFrench Dicynone 500 mg tablet label 4.8

The Irish SmPC is for the injection (licensed for newborns) but lists the effects described in adults; the French label is for the 500 mg tablet. The Indian Torrent label lists stomach pain, nausea, headache and skin rash as rare, and says they usually go away on their own. Some etamsylate tablets contain a sulphite preservative: the French tablet contains sodium sulfite, which "can, in rare cases" cause severe allergic reactions and bronchospasm (4.4), and the Torrent label warns that sulphite reactions can lead to anaphylactic shock and life-threatening asthma attacks, more often in people with asthma. We have not seen Cipla's excipient list for Ethamcip, so read the strip or carton.

When to get urgent help

Get emergency help, or ask someone to call for you, if you have:

  • Swelling of the lips, tongue, face or throat, trouble breathing or wheezing, hives or a spreading rash. Stop the tablets. The French label says hypersensitivity reactions require stopping treatment, and the Torrent label warns of anaphylactic shock with sulphite.
  • Bleeding so heavy that you feel faint, dizzy or breathless, or have a racing heart, or bleeding with severe pain. This is our advice: very heavy bleeding can lower your blood count quickly and needs assessment the same day.
  • Any bleeding when you are or could be pregnant, especially with pain on one side or shoulder tip pain. This is not a period, and etamsylate is not a treatment for it (our advice).
  • A painful swollen leg, sudden chest pain or sudden breathlessness, which can be signs of a blood clot. The Irish SmPC lists thromboembolism as a very rare effect.
  • Fever, sore throat, mouth ulcers or frequent infections, or unusual bruising or bleeding from the gums or nose. The labels list very low white cell and platelet counts; stopping the tablets and asking for a blood count is our advice. Fever alone also means stopping for good (French label 4.4).

Tell the emergency staff that you took etamsylate (Ethamcip), how much and when. The French label says no overdose has been reported and treatment would be symptomatic (4.9).

Who should not take Ethamcip 500mg

Never take it if:

  • you have had an allergic reaction to etamsylate or any ingredient of the tablet (French label 4.3; OM Pharma label; Indian Torrent label 4.3)
  • you have acute porphyria. The OM Pharma capsule label and the Indian Torrent label list acute porphyria as a contraindication; the French tablet label says etamsylate is not recommended ("déconseillé") in acute porphyria because there is no safety information
  • you have asthma with a proven sulphite allergy, if the tablet contains sulphite (Indian Torrent label 4.3, for a tablet that contains sodium metabisulphite; the Irish injection SmPC has the same contraindication). Check the Ethamcip strip for sulphite
  • you are allergic to wheat, if the tablet contains wheat starch (French label 4.3, for the French tablet). We do not know whether Ethamcip contains wheat starch
  • bleeding has not been assessed by a doctor. This is our advice, based on the French and OM Pharma indications, which assume the cause has been investigated

Not recommended, or only with care:

  • Pregnancy: the French label says that, as a precaution, it is better to avoid etamsylate during pregnancy (4.6). The Indian Torrent label says it should not be given in the first trimester, and later only if the expected benefit outweighs the risk to the baby; etamsylate crosses the placenta (5.2).
  • Breastfeeding: the French label says breastfeeding is not advised during treatment; the Torrent label says that if breastfeeding continues, the treatment must be stopped.
  • Children: the Torrent and OM Pharma labels say the 500 mg form is not appropriate for children.
  • Kidney or liver disease: etamsylate leaves the body mainly unchanged in the urine (French label 5.2), and the Torrent label says it is not known whether kidney or liver disease changes its handling. The Irish SmPC advises caution. Ask your doctor.
  • Previous fever on etamsylate: do not take it again (French label 4.4).

The French label says no clinically significant interactions are expected (4.5), and the Torrent label says none are known. That is not proof of safety with every medicine, so tell your doctor everything you take, especially other medicines for bleeding or blood clots.

Prescription and legal status

  • US: etamsylate is not approved by the FDA. openFDA lists no etamsylate or ethamsylate product (searched 21 October 2026). The FDA says personal importation of unapproved medicines is illegal in most circumstances.
  • UK: Dicynene 500 tablets (Vifor Pharma UK) were licensed but are listed in the NHS dictionary of medicines (dm+d) as discontinued and not available, as is a parallel-imported Dicynene. The electronic medicines compendium has no etamsylate product. The NHS Specialist Pharmacy Service lists etamsylate 500 mg tablets as a special-order item. We did not confirm the UK legal category.
  • Australia: we could not confirm whether any etamsylate product is registered with the TGA.
  • Canada: etamsylate is not approved; Health Canada's Drug Product Database has no etamsylate product (searched 21 October 2026).
  • France and other EU countries: Dicynone 500 mg is licensed in France without prescription and is not reimbursed; etamsylate products are also authorised in several other EU countries, including Belgium, Bulgaria, Czechia, Hungary and Slovakia (EMA list, 2025).
  • India: Apollo Pharmacy lists Ethamcip 500 as a prescription drug and Truemeds as prescription required.

Check the rules where you live, and see a doctor about heavy periods before you buy any medicine for them.

Buying genuine Ethamcip

The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and it advises UK buyers: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers this Indian pack. When your order arrives, read the strip: Apollo, PharmEasy and Truemeds list Ethamcip 500 as a strip of 10 tablets of etamsylate 500 mg from Cipla, and it should show a batch number and expiry date. Read the ingredient list for sulphite or wheat starch. These checks cannot prove that tablets are genuine, because counterfeiters copy packaging. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.

Delivery

We ship Ethamcip 500mg to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days, so it cannot help with bleeding that is happening now. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.

Other options to ask your doctor about

NICE NG88 suggests considering a levonorgestrel intrauterine system first (for example Mirena, which must be fitted by a clinician), and otherwise tranexamic acid, an NSAID such as mefenamic acid (Meftal 250mg), combined hormonal contraception (for example Loette) or cyclical oral progestogens. Each has its own risks and is a decision for your doctor. Related guide: Provera and the progestin withdrawal bleed: what bleeding, or not bleeding, tells you.

Sources

  • DICYNONE 500 mg, comprimé (etamsylate), résumé des caractéristiques du produit and notice, OMEDICAMED Unipessoal Lda, ANSM, updated 28 February 2025: sections 2, 4.1 to 4.9, 5.1, 5.2, 6.1; prescription status; HAS opinion of 8 June 2005 (SMR insufficient). Base de Données Publique des Médicaments
  • Dicynone 500 mg capsules, summary of product characteristics, OM Pharma SA, revised July 2016 (indication, posology, contraindications, undesirable effects, pharmacokinetics). Rwanda FDA
  • Styptovit E (etamsylate tablets 500 mg), prescribing information, Torrent Pharmaceuticals, India, June 2022: sections 4.1 to 4.9, 5.2, 8.4. Torrent
  • Dicynene 250 mg/2 ml solution for injection, SmPC, OM Pharma, HPRA Ireland PA 1108/1/1, revised October 2012: sections 4.2, 4.3, 4.8, 5.1. HPRA
  • NHS dictionary of medicines and devices (dm+d): Dicynene 500 tablets (Vifor Pharma UK Ltd) and Dicynene 500 tablets (Dowelhurst Ltd, parallel import), both discontinued and not available; checked 21 October 2026. dm+d browser
  • NICE. Heavy menstrual bleeding: assessment and management (NG88), published 14 March 2018, last updated 7 July 2026: recommendations 1.2.6, 1.2.7, 1.3.4, 1.3.10, 1.5.2, 1.5.3, and update information. NICE
  • National Collaborating Centre for Women's and Children's Health. Heavy menstrual bleeding, clinical guideline (CG44 full guideline), January 2007: section 8.12 and chapter 8 recommendations. NICE
  • Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996;313:579 to 582. PMID 8806245.
  • Bryant-Smith AC, Lethaby A, Farquhar C, Hickey M. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2018;4:CD000249. PMID 29656433.
  • Bofill Rodriguez M, Lethaby A, Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2019;9:CD000400. PMID 31535715.
  • Tranexamic acid tablets, US prescribing information, Actavis Pharma (DailyMed setid 3f07e93b-3568-487e-894f-8f90e5a0960a, version 18, March 2026): sections 1, 2, 4, 5.1. DailyMed
  • Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC) 2026: tranexamic acid 650 mg tablet $0.82949 (10 NDC rows), effective 21 October 2026; no etamsylate rows. data.medicaid.gov
  • US Food and Drug Administration, openFDA drug approvals and NDC directory: no etamsylate or ethamsylate product; searched 21 October 2026.
  • Health Canada Drug Product Database: no etamsylate product; searched 21 October 2026. Health Canada
  • European Medicines Agency. List of nationally authorised medicinal products, etamsylate, PSUSA/00001294/202506, 2025. EMA
  • Indian pharmacy listings for Ethamcip 500 (Apollo Pharmacy, PharmEasy, Truemeds), checked 21 October 2026.
  • MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
  • US Food and Drug Administration. Personal Importation. FDA

This page is for information and is not medical advice. Heavy menstrual bleeding needs assessment by a doctor, and better tested treatments than etamsylate exist. Take any medicine for it only as prescribed.

Frequently asked questions

What is Ethamcip 500mg?

Ethamcip 500mg is Cipla's etamsylate (ethamsylate) 500 mg tablet, sold in India mainly for heavy menstrual bleeding and bleeding from small blood vessels. It is not a hormone and not a contraceptive. The labels say it works on platelet adhesion and the walls of small blood vessels. The evidence that it reduces heavy periods is weak, and we would not recommend it when better tested treatments exist.

Is Ethamcip the same as Dicynene or Dicynone?

It contains the same medicine, etamsylate 500 mg. Dicynene was the UK brand and is now listed in the NHS dictionary of medicines as discontinued and not available; Dicynone 500 mg is still licensed in France without prescription. We have not seen any study comparing Cipla's Ethamcip with Dicynone, and we have not seen Ethamcip's full ingredient list, so check the strip for sulphite or wheat starch.

Does etamsylate work for heavy periods?

Not well, on the evidence we found. In a 1996 BMJ trial of 76 women, etamsylate did not reduce mean menstrual blood loss, while tranexamic acid reduced it by 54% and mefenamic acid by 20% (PMID 8806245). A 2018 Cochrane review found tranexamic acid reduced blood loss by 100 mL per cycle more than etamsylate. NICE's 2007 guideline (since replaced by NG88, which does not recommend etamsylate) said etamsylate should not be used for heavy menstrual bleeding, and France rated its benefit insufficient.

What does Ethamcip 500mg cost per tablet?

As of October 2026 it costs $0.83 a tablet in the 30 pack and $0.75 in the 60 pack, before shipping. Both packs are under $149, so each carries $25 shipping: $1.67 and $1.17 a tablet with shipping. The pack selector shows the current price.

How do I take Ethamcip 500mg?

Only after a doctor has assessed the bleeding, and as prescribed. The OM Pharma and Indian Torrent etamsylate labels say one 500 mg tablet three times a day with meals for 10 days, starting 5 days before the expected period; the French label says three tablets a day. NICE's 2007 guideline described 500 mg four times a day from the start of bleeding. If you develop a fever, stop and do not restart (French label).

Should I choose Ethamcip 250mg or 500mg?

Every label we read uses a 500 mg single dose, so Ethamcip 500mg is one tablet per dose and Ethamcip 250mg needs two. None of the labels sets a higher dose for heavy periods or suggests that more tablets work better. The Torrent label says the 500 mg tablet is not appropriate for children.

How long does a pack last?

On the 10 day schedule of three tablets a day, one cycle uses 30 tablets, so the 30 pack covers one cycle and the 60 pack two. On the four times a day schedule for 5 days of bleeding, a cycle uses 20 tablets. That is our arithmetic. The labels say that if bleeding does not improve, the cause must be looked for, so do not stock up before a doctor has assessed you.

What are the side effects of Ethamcip?

The Irish Dicynene SmPC lists nausea, diarrhoea, abdominal discomfort, headache, rash and weakness as common in adults, and fever, blood clots, low blood pressure and very low white cell or platelet counts as very rare. The French tablet label adds allergic reactions, mainly hives, which mean stopping treatment. Some etamsylate tablets contain sulphite, which can cause severe allergic reactions and asthma attacks in sensitive people.

Who should not take Ethamcip 500mg?

Do not take it if you are allergic to etamsylate or any ingredient, or if you have acute porphyria (a contraindication in the OM Pharma and Indian Torrent labels; the French label says not recommended). Avoid it if you have asthma with a proven sulphite allergy or a wheat allergy and the tablet contains sulphite or wheat starch. The French label advises avoiding it in pregnancy as a precaution and says breastfeeding is not advised. Do not take it again if it gave you a fever.

Do I need a prescription for Ethamcip 500mg?

Etamsylate is not approved in the US or Canada, the UK Dicynene 500 tablet is discontinued, and we could not confirm its status in Australia. In France Dicynone 500 mg is sold without prescription; in India Apollo and Truemeds list Ethamcip 500 as prescription required. The FDA says personal importation of unapproved medicines is illegal in most circumstances. Whatever the rules, heavy periods need a doctor's assessment first.

How long does delivery take?

Standard delivery takes 7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking, so it cannot help with bleeding that is happening now. Shipping is a flat $25 on orders under $149 and free from $149. If bleeding is very heavy, or you feel faint, dizzy or breathless, get medical help straight away.

Guide to Female Infertility & Ovulation InductionHow clomiphene triggers ovulation in PCOS and anovulatory women, success rates, dosing protocol, how to time sex around Clomid, and what to do if it does not work.

Related articles

Customer Reviews

No reviews yet. Bought Ethamcip 500mg? Tell other buyers how it went.